3 weeks VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up Zacks

The FDA approves Vertex’s non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

Pharmaceuticals · Vertex (VRTX)